Networking Event Series – Biotech toolkit (CSL Behring) – empowered by Innosuisse (EN)

Date

23.09.21

Time

16:00 - 18:00

Location

Online
Stephan Emmerth

Organizer

Stephan Emmerth
Email
stephan.emmerth@baselarea.swiss

Partnering with CSL Behring: our commitment to serious and rare diseases

Join the networking event series “Biotech Toolkit” empowered by Innosuisse and get some deep insights on how to translate ground-breaking science into successful biotech companies.

CSL is a leading research-driven global biotech company that develops and delivers a broad range of innovative lifesaving therapies to treat serious and often rare disorders. CSL continuously seeks to identify and build relationships with various players from across Europe in an effort to identify breakthrough technologies and novel therapeutic modalities that can feed and support the growth of its internal pipeline, and ultimately deliver new medicines to patients with significant unmet needs.

Join us in this event with CSL Behring to hear great stories and lessons learned on successful partnership. You will discover how to connect and engage with CSL, learn about their areas of interest and much more.

Program

16:00

Welcome
Stephan Emmerth, BaseLaunch

16:10

CSL Behring: a leading global biotech company focusing on serious and rare disease
Adrian Zuercher, VP Research Europe and Head Plasma Protein Research

16:25

Partnering with CSL Behring: areas of interest for early-stage partnering
Samantha Brandler, Director Research External Innovation Europe

16:40

Choices & Challenges in early capital raises
Stephanie Read, VP Strategy & Business Development

17:55

Q&A and Networking

Participation is free, however registration is required before September 22, 2021.

Our partner